https://www.dovepress.com/feed/journal/113New articles released by Dove Press for Biosimilarsen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press Biosimilarshttps://www.dovepress.com/feed/journal/113https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140https://www.dovepress.com/physicochemical-and-biological-comparison-of-the-first-brazilian-biosi-peer-reviewed-fulltext-article-BSBiosimilarsTue, 30 Aug 2016 12:06:00 +1200https://doi.org/10.2147/BS.S107898https://www.dovepress.com/adalimumab-a-review-of-the-reference-product-and-biosimilars-peer-reviewed-fulltext-article-BSBiosimilarsTue, 26 Jul 2016 13:16:00 +1200https://doi.org/10.2147/BS.S98177https://www.dovepress.com/quotstepquot-versus-quotphasequot-in-the-clinical-development-of-biosi-peer-reviewed-fulltext-article-BSBiosimilarsWed, 22 Jun 2016 11:37:00 +1200https://doi.org/10.2147/BS.S105910https://www.dovepress.com/tools-for-the-analysis-and-characterization-of-therapeutic-protein-spe-peer-reviewed-fulltext-article-BSBiosimilarsThu, 05 May 2016 15:02:00 +1200https://doi.org/10.2147/BS.S68103https://www.dovepress.com/considerations-in-biosimilar-insulin-device-development-peer-reviewed-fulltext-article-BSBiosimilarsTue, 16 Feb 2016 14:49:00 +1300https://doi.org/10.2147/BS.S77034https://www.dovepress.com/development-safety-and-efficacy-of-biosimilar-adalimumab-the-data-so-f-peer-reviewed-fulltext-article-BSBiosimilarsFri, 29 Jan 2016 13:56:00 +1300https://doi.org/10.2147/BS.S55900https://www.dovepress.com/pharmacokinetic-and-pharmacodynamic-properties-of-a-new-biosimilar-fil-peer-reviewed-fulltext-article-BSBiosimilarsTue, 03 Nov 2015 13:56:00 +1300https://doi.org/10.2147/BS.S86638https://www.dovepress.com/label-free-interaction-analysis-as-a-tool-to-demonstrate-biosimilarity-peer-reviewed-fulltext-article-BSBiosimilarsWed, 16 Sep 2015 13:32:00 +1200https://doi.org/10.2147/BS.S85537https://www.dovepress.com/low-immunogenicity-but-reduced-bioavailability-of-an-interferon-beta-1-peer-reviewed-fulltext-article-BSBiosimilarsTue, 15 Sep 2015 11:40:00 +1200https://doi.org/10.2147/BS.S81908https://www.dovepress.com/clinical-efficacy-and-safety-of-biosimilar-epoetin-focus-on-epoetin-ze-peer-reviewed-fulltext-article-BSBiosimilarsWed, 09 Sep 2015 11:35:00 +1200https://doi.org/10.2147/BS.S50456https://www.dovepress.com/clinical-trials-in-the-development-of-biosimilars-future-consideration-peer-reviewed-fulltext-article-BSBiosimilarsThu, 09 Jul 2015 17:31:00 +1200https://doi.org/10.2147/BS.S59825https://www.dovepress.com/establishing-a-new-marketplace-for-biologic-therapy-with-biosimilar-ag-peer-reviewed-fulltext-article-BSBiosimilarsMon, 01 Jun 2015 14:20:00 +1200https://doi.org/10.2147/BS.S78896https://www.dovepress.com/challenging-issues-in-assessing-analytical-similarity-in-biosimilar-st-peer-reviewed-fulltext-article-BSBiosimilarsFri, 22 May 2015 10:46:00 +1200https://doi.org/10.2147/BS.S84141https://www.dovepress.com/global-regulatory-landscape-of-biosimilars-emerging-and-established-ma-peer-reviewed-fulltext-article-BSBiosimilarsTue, 17 Feb 2015 10:08:00 +1300https://doi.org/10.2147/BS.S44052https://www.dovepress.com/physicochemical-and-functional-characterization-of-a-biosimilar-adalim-peer-reviewed-fulltext-article-BSBiosimilarsWed, 31 Dec 2014 12:04:00 +1300https://doi.org/10.2147/BS.S75573https://www.dovepress.com/production-and-manufacturing-of-biosimilar-insulins-implications-for-p-peer-reviewed-fulltext-article-BSBiosimilarsMon, 10 Nov 2014 12:15:00 +1300https://doi.org/10.2147/BS.S36043https://www.dovepress.com/multidisciplinary-approach-to-evaluating-immunogenicity-of-biosimilars-peer-reviewed-fulltext-article-BSBiosimilarsWed, 25 Jun 2014 00:00:00 +1200https://doi.org/10.2147/BS.S50012https://www.dovepress.com/production-and-analysis-of-a-biosimilar-erythropoietin-in-egypt-peer-reviewed-fulltext-article-BSBiosimilarsSat, 10 May 2014 00:00:00 +1200https://doi.org/10.2147/BS.S60038https://www.dovepress.com/clinical-efficacy-and-safety-of-zarzioreg-ep2006-a-biosimilar-recombin-peer-reviewed-fulltext-article-BSBiosimilarsWed, 12 Mar 2014 00:00:00 +1300https://doi.org/10.2147/BS.S28710https://www.dovepress.com/clinical-efficacy-and-safety-of-xm01-a-biosimilar-recombinant-human-er-peer-reviewed-fulltext-article-BSBiosimilarsTue, 27 Aug 2013 00:00:00 +1200https://doi.org/10.2147/BS.S28709https://www.dovepress.com/clinical-efficacy-and-safety-of-tevagrastimreg-xm02-a-biosimilar-recom-peer-reviewed-fulltext-article-BSBiosimilarsTue, 27 Aug 2013 00:00:00 +1200https://doi.org/10.2147/BS.S27712https://www.dovepress.com/clinical-efficacy-and-safety-of-sb309-a-biosimilar-recombinant-human-e-peer-reviewed-fulltext-article-BSBiosimilarsWed, 21 Aug 2013 00:00:00 +1200https://doi.org/10.2147/BS.S28708https://www.dovepress.com/current-and-future-biosimilars-potential-practical-applications-in-rhe-peer-reviewed-fulltext-article-BSBiosimilarsThu, 01 Aug 2013 00:00:00 +1200https://doi.org/10.2147/BS.S35683https://www.dovepress.com/rituximab-and-biosimilars-ndash-equivalence-and-reciprocity-peer-reviewed-fulltext-article-BSBiosimilarsFri, 14 Jun 2013 00:00:00 +1200https://doi.org/10.2147/BS.S20681https://www.dovepress.com/similar-biotherapeutic-products-in-latin-america-regulation-and-opport-peer-reviewed-fulltext-article-BSBiosimilarsFri, 04 Jan 2013 00:00:00 +1300https://doi.org/10.2147/BS.S38572https://www.dovepress.com/a-european-perspective-on-the-market-accessibility-of-biosimilars-peer-reviewed-fulltext-article-BSBiosimilarsFri, 16 Nov 2012 00:00:00 +1300https://doi.org/10.2147/BS.S33524https://www.dovepress.com/the-development-and-introduction-of-biosimilar-anticoagulants-ndash-fo-peer-reviewed-fulltext-article-BSBiosimilarsThu, 13 Sep 2012 00:00:00 +1200https://doi.org/10.2147/BS.S17831https://www.dovepress.com/clinical-efficacy-and-safety-of-hx575-a-biosimilar-recombinant-human-e-peer-reviewed-fulltext-article-BSBiosimilarsThu, 06 Sep 2012 00:00:00 +1200https://doi.org/10.2147/BS.S28707https://www.dovepress.com/critical-appraisal-of-biosimilar-filgrastim-nivestimtrade-for-febrile--peer-reviewed-fulltext-article-BSBiosimilarsMon, 20 Aug 2012 00:00:00 +1200https://doi.org/10.2147/BS.S17420https://www.dovepress.com/scientific-factors-for-assessing-biosimilarity-and-drug-interchangeabi-peer-reviewed-fulltext-article-BSBiosimilarsThu, 16 Jun 2011 00:00:00 +1200https://doi.org/10.2147/BS.S20577